Drug Approval | July 05, 2022
Sanofi flu vaccines licensed and approved for 2022-2023 influenza season
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
It is a two dose vaccine to be administered intramuscularly at 28 days apart
We must try to make the health care system more accessible for people with disabilities
Doctors will study for a Master of Surgery or Master of Medicine degree at Edge Hill University.
First and only PARP inhibitor to improve invasive disease-free survival in patients
Tabrecta is the number one prescribed targeted therapy for advanced NSCLC with alterations leading to METex14 skipping globally
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
Subscribe To Our Newsletter & Stay Updated
